Pharmaceutical News and Articles

Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma

On November 1, Nanjing Leads Biolabs Co., Ltd. (hereinafter referred to as Leads Biolabs ) announced that LBL-034, a humanized bispecific T-cell engaging antibo

JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio's Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma

SHANGHAI, NANJING, and SAN JOSE, CA., November 07, 2024 IASO Biotherapeutics ( IASO Bio ), a biopharmaceutical company dedicated to discovering, developing, man

FDA Approves Aucatzyl (obecabtagene autoleucel) for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

American College of Gastroenterology, Oct. 25-30

The annual meeting of the American College of Gastroenterology was held from Oct. 25 to 30 in Philadelphia and attracted participants from around the world, inc

Racial, Ethnic Differences Seen in Cleft Lip Surgery Repair

Racial and ethnic differences are seen with primary cleft lip surgery repair, according to a study published online in the November issue of Plastic and Reconst

Men Aged >16 to to <55 years at increased risk for acute kidney injury (AKI)

Boys and men aged 16 to 55 years have an increased risk for acute kidney injury (AKI) during hospitalization, according to a study published online Oct. 22 in t

Expanded Admission Screening Protocol for Candida Auris Beneficial

Health care facilities should consider initiating or expanding admission screening for Candida auris based on community prevalence rates, according to a study p

Heat Waves Linked to Adverse Health Outcomes for Seniors

For dually eligible adults aged 65 years and older, heat waves are associated with increased adverse health events, according to a study published online Nov. 8

Men Aged >16 to

Boys and men aged 16 to 55 years have an increased risk for acute kidney injury (AKI) during hospitalization, according to a study published online Oct. 22 in t

Decline Expected in HIV Care Providers in Next Five Years

The supply of health care professionals available to provide HIV care is expected to continue to decline over the next five years, according to research publish